Clinical Report: Comprehensive Analysis of the Largest Consecutive Robotic Pneumonectomy Series
Background
Robotic pneumonectomy remains underutilized. The procedure is particularly relevant for patients with complex conditions such as advanced lung cancer and those who have undergone neoadjuvant therapies. Understanding the outcomes of robotic pneumonectomy can help inform surgical practices and patient management strategies.
Data Highlights
Parameter
Value
Number of Patients
21
Median Age
70
30-Day Readmission Rate
19%
30-Day Morbidity
19%
90-Day Mortality
5%
Key Findings
Robotic pneumonectomy was performed on 21 patients, with 67% being male.
The median age of patients was 70 years, with a range of 15 to 79 years.
Indications for surgery included cancer in 81% of cases, primarily lung cancer.
Neoadjuvant therapy was administered to 76% of cancer patients.
The median length of hospital stay was five days, with a range of 1 to 25 days.
No intraoperative transfusions were required, and 30-day mortality was 0%.
Clinical Implications
The findings suggest that robotic pneumonectomy can be safely performed in high-risk patients, with minimal conversion to open surgery and no need for blood transfusions. These outcomes may encourage broader adoption of robotic techniques in thoracic surgery.
Conclusion
Robotic pneumonectomy demonstrates promising short-term outcomes and can be considered a viable option for patients requiring this complex surgical intervention.